|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Characterization of DNA-strand breakage induced in V79 cells by F 11782, a catalytic inhibitor of topoisomerases显示文摘 | Barret JM Hill BT Olive PL | 2000 | Br J Cancer2000，83，12： | 1 |
| 2 | Characterization of the biological and biochemical activities of F 11782 and the bisdiox-opiperazines, ICRF- 187 and ICRF-193, two types of topoi-somerase Ⅱ catalytic inhibitors with distinctive mechanisms ofaction显示文摘 | van Hille B Etievant C Barret JM | 2000 | Anti Cancer Drugs2000，11，10： | 1 |
| 3 | DNA repair mechanisms associated with cellular resistance to antitumor drugs : potential novel targets显示文摘 | Barret JM Hill BT | 1998 | Anticancer Drugs1998，9，2： | 1 |
| 4 | A cisplatin-resistant murine leukemia cell line exhibits increased topoisomerase Ⅱ activity 显示文摘 | Barret JM Calsou P Larsen AK | 1994 | Mol Pharmacol1994，46，3： | 1 |
| 5 | F 11782, a dual inhibitor of topoisomerases Ⅰ and Ⅱ with an original mechanism of action in vitro and markedly superior in vivo antitumor activity, relative to three other dual topoisomeraseinhibitors, intoplicin, aclarubicin TAS-103 显示文摘 | Etievant C Kruczynski A Barret JM | 2000 | Cancer Chemother Pharmacol2000，46，： | 1 |
| 6 | F14512, a potent antitumor agent targeting topoisomerase II vectored into cancer cells via the polyarnine transport system 显示文摘 | Barret JM Kruczynski A Visp6 S | 2008 | Cancer Res2008，68，： | 1 |
| 7 | Full face transplantation organization, development, and results-the Barcelona experience: a case report 显示文摘 | Barret JP Serracanta J Collado JM | 2011 | Transplant Proc2011，43，9： | 1 |
| 8 | In vitro synergistic effects of vinflunine, a novel fluorinated vinca alkaloid in combination with other anticancer drugs 显示文摘 | BARRET JM ETIEVANT C HILL BT | 2000 | Cancer Chemther Pharmacol2000，45，6： | 1 |
| 9 | Synergistic effects of F11782, a novel dual inhibitor of topoisomerase Ⅰ and Ⅱ,in cimbination with other anticancer agents 显示文摘 | Kruczynski A Etievant C | 2002 | Cancer Chemother Pharmacol2002，49，6： | 1 |
| 10 | Decreased nucleotide excision rpair activity and zlterations of topoisomerase IIalpha are associated with the in vivo resistance of a P388 leukemia subline to F11782, a novel catalytic inhibitor of topoisomerases I and II 显示文摘 | Kruczynski A Barret JM Van Hille B | 2004 | Clin Cancer Res2004，10，： | 1 |
| 11 | Synergisticeffects of Fu782,a novel dual inhibitor of topoisomerase Ⅰ and Ⅱ, in combination with other anticancer agents显示文摘 | Barret JM Kruczynski A Etievant C | 2002 | J Cancer chemother pharmacal2002，49，6： | 1 |
| 12 | A cisplatin-resistant murine leukemia cell line exhibits increased topoisomerase Ⅱ activity显示文摘 | Barret JM Calsou P Larsen AK | 1994 | Mol Pharmacol1994，46，： | 1 |
| 13 | One-step customized transurethral resection of the prostate and permanent implant brachytherapy for selected prostate cancer patients: technically feasible but too toxic显示文摘 | Cosset JM Barret E Castro-Pena P | 2011 | Brachytherapy2011，10，： | 1 |
| 14 | Decreased nu- cleotide excision repair activity and alterations of topoisomer- ase Ⅱ alpha are associated with the in vivo resistance of a P388 leukemia subline to F11782, a novel catalytic inhibitor of topoisomerases Ⅰ and Ⅱ 显示文摘 | Kruezynski A Barret JM Van Hille B etal | 2004 | Clin Cancer Res2004，10，31： | 1 |
| 15 | Microfoam ultrasoundguided sclerotherapy of varicose veins in 100 legs显示文摘 | Barret JM Allen B Ockelford A | 2004 | Dermatol Surg2004，30，1： | 1 |
| 16 | Antimitotic and tubulininteracting properties of vinflunine, a novel Vinca alkaloid 显示文摘 | Kruczynski A Barret JM Etievant C | 1998 | Biochem Phannaed1998，55，5： | 1 |
| 17 | Decreased nucleotide excision repair activity and alterations of topoisomerase Ⅱ alpha are associated with the in vivo resistance of a P388 leukemia subline to Fl1782,a novel catalytic inhibitor of topoisomerases Ⅰ and Ⅱ显示文摘 | Kruczynski A Barret JM Van Hille B | 2004 | Clin Cancer Res2004，10，9： | 1 |
| 18 | F 11782, a novel epipo-dophylloid non-intercalating dual catalytic inhibitor of topoi-somerases Ⅰ and Ⅱ with an original mechanism of action显示文摘 | Perrin D van Hille B Barret JM | 2000 | Biochem Pharmacol2000，59，7： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员